Giulia Pinton

Novara, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

Journal: Oncogenesis

Published: June 18, 2026

Defined pulsed electro-magnetic field exposure suppresses stemness and potentiates temozolomide-induced apoptosis in glioblastoma cells.

Defined pulsed electro-magnetic field exposure suppresses stemness and potentiates temozolomide-induced apoptosis in glioblastoma cells.

Journal: Scientific reports

Published: November 26, 2025

An analysis of succinate dehydrogenase B in pleural mesothelioma.

An analysis of succinate dehydrogenase B in pleural mesothelioma.

Journal: Discover oncology

Published: September 25, 2025

EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype.

EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype.

Journal: International journal of molecular sciences

Published: September 04, 2025

EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure.

EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure.

Journal: Nutrients

Published: July 30, 2024

A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

Journal: Cancers

Published: April 26, 2024

Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1.

Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1.

Journal: Cancers

Published: May 02, 2023

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

Journal: International journal of molecular sciences

Published: March 16, 2023

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma.

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma.

Journal: Cancers

Published: February 01, 2023

Epigenetic Insights on PARP-1 Activity in Cancer Therapy.

Epigenetic Insights on PARP-1 Activity in Cancer Therapy.

Journal: Cancers

Published: November 11, 2022

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition.

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition.

Journal: Frontiers in oncology

Published: October 27, 2022

The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake.

The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake.

Journal: Bioinorganic chemistry and applications

Published: October 25, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026